Frontage Holdings Corp Sustainability Reports
Frontage Holdings Corporation operates as a contract research organization (CRO) that provides integrated drug discovery and development services. The company specializes in bioanalysis, safety and toxicology, preclinical and clinical studies, and product development services for biopharmaceutical companies.
Sector: Professional & technical services
Country: United States
Exchange: Hong Kong Stock Exchange
ISIN: KYG3679P1019
10 reports from 2019 to 2025